TLO - Delayed Quote EUR
Organon & Co. (4OGN.TI)
8.01
+0.06
+(0.81%)
At close: May 6 at 9:40:25 AM GMT+2
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 5 | 5 | 7 | 7 |
| Avg. Estimate | 1.53B | 1.56B | 6.29B | 6.36B |
| Low Estimate | 1.5B | 1.54B | 6.16B | 6.15B |
| High Estimate | 1.58B | 1.59B | 6.6B | 6.79B |
| Year Ago Sales | 1.62B | 1.61B | 6.4B | 6.29B |
| Sales Growth (year/est) | -5.48% | -3.23% | -1.77% | 1.07% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| 4OGN.TI | -- | -- | -- | -- |
| S&P 500 | 12.66% | 3.22% | 7.99% | 13.82% |
Upgrades & Downgrades
| Maintains | Morgan Stanley: Equal-Weight to Equal-Weight | 4/9/2025 |
| Maintains | Barclays: Overweight to Overweight | 2/14/2025 |
| Maintains | Morgan Stanley: Equal-Weight to Equal-Weight | 2/14/2025 |
| Downgrade | JP Morgan: Neutral to Underweight | 9/6/2024 |
| Maintains | Goldman Sachs: Neutral to Neutral | 5/6/2024 |
| Maintains | Goldman Sachs: Neutral to Neutral | 5/3/2024 |